Report Type : Therapy Reports

Report Category : Male Health

Report Subcategory : Benign Prostatic Hyperplasia

Price : 1099.00

Date : December 2022

Benign Prostatic Hyperplasia : Global Market Landscape till 2030 - Epidemiology, Drugs, Trials, Technology, Companies, News, Deals, Patents, Drug Sales & Forecast, Future Events, DMF, and Manufacturing

Top 50 Key Players:

1. Novartis AG
2. Merck & Co Inc
3. GlaxoSmithKline Plc
4. Sanofi
5. Bristol-Myers Squibb Co
6. Eli Lilly and Co
7. Suzuken Co Ltd
8. Teva Pharmaceutical Industries Ltd
9. Astellas Pharma Inc
10. Meiji Holdings Co Ltd
11. Ono Pharmaceutical Co Ltd
12. Nippon Shinyaku Co Ltd
13. Chong Kun Dang Pharmaceutical Corp
14. Kaken Pharmaceutical Co Ltd
15. Sihuan Pharmaceutical Holdings Group Ltd
16. ASKA Pharmaceutical Co Ltd
17. Dongkook Pharmaceutical Co Ltd
18. Jeil Pharmaceutical Co Ltd
19. DongKoo Bio & Pharma Co Ltd
20. GemVax & KAEL Co Ltd
21. Addex Therapeutics Ltd
22. MEI Pharma Inc
23. TiumBio Co Ltd
24. Nymox Pharmaceutical Corp
25. Sophiris Bio Inc
26. Allergan Plc
27. Kolmar Group AG
28. Light Sciences Oncology Inc
29. Curadis GmbH
30. Veru Inc
31. Health Ever Bio-Tech Co Ltd
32. Teva Takeda Pharma Ltd
33. AlfaSigma SpA
34. Teva-Kowa Pharma Co Ltd
35. Kobayashi Kako Co Ltd
36. ratiopharm GmbH
37. Krebs Biochemicals And Industries Ltd
38. AndroScience Corp
39. Valeant Pharmaceuticals International Inc
40. Everon Biosciences Inc
41. Council Scientific and Industrial Research
42. Pfizer Inc
43. Bayer AG
44. Merck & Co Inc
45. GlaxoSmithKline Plc
46. Sanofi
47. AbbVie Inc
48. Abbott Laboratories
49. Takeda Pharmaceutical Co Ltd
50. Teva Pharmaceutical Industries Ltd